UAE pharmaceutical market is anticipated
to register growth with an impressive CAGR in the forecast period, 2023-2027,
on the account of expanding healthcare industry and investment in the industry.
Surging demands from the growing population of the country for efficient
pharmaceutical products are further driving the growth of the UAE
pharmaceutical market in the upcoming five years.
Government Initiatives Drive Market
Growth
United Arab Emirates’ government is
actively focused on advancing the pharmaceutical industry. Initiatives like the
Dubai Industrial Strategy 2030 and the Abu Dhabi vision 2030 is focused toward
developing the pharmaceutical industry due to its future growth prospects,
export potential and mid-term to long-term economic impact. Till recent past,
the country pharmaceutical demands were highly met through imported drugs and
pharmaceutical products. Going forward, the country is actively functioning to
decrease the import of pharmaceutical and manufacture their own products
through increasing investments in pharmaceutical and therapeutic products’
research and development.
In the year 2018, country imported
pharmaceutical products worth over USD14.9 billion from the countries like Germany,
USA, France and Switzerland. To increase their self-production of
pharmaceutical products the country is initiating bonds with multinational
market players. With favorable schemes and plans for the distribution channels
and funding strategic location and sophisticated logistics infrastructure is
also anticipated to further strengthen the growth of the UAE pharmaceutical
market in the future five years.
India – UAE Bilateral Trade Supports
Pharmaceutical Industry
India stands 3rd in terms of
pharmaceutical products volume production and 14th in terms of value
of the industry across the world. With the historic partnership, the countries
are trying to establish a conjugated pharmaceutical industry that would benefit
the industry in both countries. Moreover, with the recent pandemic effect the
import-export channels have suffered drastically in recent years. Therefore,
UAE is trying to establish more permanent solution to the surging demands for
the pharmaceutical products in the country.
Growing Instances Of Diseases Upsurges
Drug Demands
Increasing number of chronic diseases,
infectious diseases, and lifestyle diseases are major factor influencing the
growth of the pharmaceutical market in the country. Chronic diseases like
cardiovascular diseases, cancer, neurological disorders, etc. are driving the
market growth. 4,807 new cancer cases were observed in the country among both
male and female population in the country.
Infectious diseases due to higher
tourism, and environmental factor, and the recent viral infection due to
COVID-19 facilitated the demand for pharmaceutical products. Disrupted import
channels, have pushed the pharmaceutical companies in the country to
manufacture drugs and medicines in the country and government also supported
the notion with higher investment in the sector.
Click here to download the sample
Market Segmentation
The UAE pharmaceutical
market is segmented by drug type, product type, application, distribution
channel, competitional landscape, and regional distribution. Based on drug type, the market is
differentiated between generic drugs and branded drugs. Product type based
market segment is divided between prescription drugs and over the counter drugs.
Application based market segment is further fragmented into cardiovascular,
musculoskeletal, oncology, anti-infective, metabolic disorder, and others. Based
on distribution channel, the market is bifurcated into retail pharmacy,
hospital pharmacy, and e-pharmacy. The market analysis also studies the
regional segmentation to devise regional market segmentation, divided among Dubai
region, Sharjah region, Abu Dhabi region and the rest of the UAE.
Company Profile
Julphar Gulf Pharmaceutical Industries, Bayer
Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline
& Neopharma, Pfizer UAE, Johnson & Johnson Middle East FZ-LLC, among others is a partial list of
major market players of the companies responsible for the growth of UAE pharmaceutical
market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historical Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments covered
|
·
Drug Type
·
Product Type
·
Application
·
Distribution Channel
|
|
Regional scope
|
Northern
region, Central region, and Southern region.
|
|
Key companies profiled
|
Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health,
Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma,
Pfizer UAE, Johnson & Johnson Middle East FZ-LLC
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, UAE pharmaceutical market has been segmented into
following categories, in addition to the industry trends which have also been
detailed below:
- UAE Pharmaceutical Market, By Drug Type:
- Generic Drugs
- Branded Drugs
- UAE Pharmaceutical Market, By Product
Type:
- Prescription Drugs
- Over-The-Counter Drugs
- UAE Pharmaceutical Market, By Application:
- Cardiovascular
- Musculoskeletal
- Oncology
- Anti-infective
- Metabolic Disorder
- Others
- UAE Pharmaceutical Market, By Distribution
Channel:
- Retail Pharmacy
- Hospital Pharmacy
- E-Pharmacy
- UAE Pharmaceutical Market, By
Region:
o Dubai Region
o Sharjah Region
o Abu Dhabi Region
o Rest of UAE
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in UAE pharmaceutical market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
UAE Pharmaceutical Market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]
In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]